Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9408 |
High Similarity |
NPD2801 |
Approved |
0.9342 |
High Similarity |
NPD1934 |
Approved |
0.9231 |
High Similarity |
NPD5494 |
Approved |
0.9156 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9038 |
High Similarity |
NPD3882 |
Suspended |
0.8882 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD6166 |
Phase 2 |
0.8816 |
High Similarity |
NPD1511 |
Approved |
0.8773 |
High Similarity |
NPD3818 |
Discontinued |
0.8734 |
High Similarity |
NPD3817 |
Phase 2 |
0.8733 |
High Similarity |
NPD1549 |
Phase 2 |
0.8701 |
High Similarity |
NPD1512 |
Approved |
0.8679 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD7074 |
Phase 3 |
0.8667 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD7054 |
Approved |
0.8606 |
High Similarity |
NPD5844 |
Phase 1 |
0.8599 |
High Similarity |
NPD4380 |
Phase 2 |
0.8598 |
High Similarity |
NPD7473 |
Discontinued |
0.8554 |
High Similarity |
NPD7472 |
Approved |
0.8553 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD1510 |
Phase 2 |
0.8528 |
High Similarity |
NPD6232 |
Discontinued |
0.8509 |
High Similarity |
NPD7075 |
Discontinued |
0.8509 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8438 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8393 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8389 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8354 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8313 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.828 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8272 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8253 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.825 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8146 |
Intermediate Similarity |
NPD943 |
Approved |
0.8129 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8023 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD919 |
Approved |
0.8 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7962 |
Intermediate Similarity |
NPD2800 |
Approved |
0.795 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7912 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7885 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7885 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7881 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7848 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7834 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7821 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7809 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1933 |
Approved |
0.774 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD920 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7711 |
Intermediate Similarity |
NPD37 |
Approved |
0.7707 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7679 |
Intermediate Similarity |
NPD4965 |
Approved |
0.767 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7607 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD9494 |
Approved |
0.758 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7548 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7485 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7457 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7446 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7446 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7439 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7434 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7316 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7229 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD17 |
Approved |
0.717 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7166 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7134
|
Intermediate Similarity |
NPD3018 |
Phase 2 |